Amer Zeidan, Chief of the Division of Hematologic Malignancies and Professor of Medicine at Yale University, shared a post on X:
“Community Practice Connections: Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals.”
More Posts Featuring MDS.